PW MEDTECH GROUP DL-0001 (PWE) - Total Liabilities
Based on the latest financial reports, PW MEDTECH GROUP DL-0001 (PWE) has total liabilities worth €381.52 Million EUR (≈ $446.04 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PW MEDTECH GROUP DL-0001 (PWE) equity growth momentum to track the company's year-over-year net asset growth rate.
PW MEDTECH GROUP DL-0001 - Total Liabilities Trend (2021–2025)
This chart illustrates how PW MEDTECH GROUP DL-0001's total liabilities have evolved over time, based on quarterly financial data.
PW MEDTECH GROUP DL-0001 Competitors by Total Liabilities
The table below lists competitors of PW MEDTECH GROUP DL-0001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
1911 Gold Corp
V:AUMB
|
Canada | CA$9.87 Million |
|
INFOM
KLSE:0265
|
Malaysia | RM244.87 Million |
|
West Wits Mining Ltd
AU:WWI
|
Australia | AU$22.12 Million |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
USA | $15.00 Million |
|
King Core Electronics Inc
TW:6155
|
Taiwan | NT$649.91 Million |
|
Ellsworth Convertible Growth & IF
NYSE MKT:ECF
|
USA | $1.19 Million |
|
Alumil Aluminium Industry S.A
AT:ALMY
|
Greece | €337.09 Million |
|
Orbitech Co. Ltd
KQ:046120
|
Korea | ₩56.53 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down PW MEDTECH GROUP DL-0001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PWE market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PW MEDTECH GROUP DL-0001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PW MEDTECH GROUP DL-0001 (2021–2025)
The table below shows the annual total liabilities of PW MEDTECH GROUP DL-0001 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €381.52 Million ≈ $446.04 Million |
+6.70% |
| 2024-12-31 | €357.56 Million ≈ $418.03 Million |
+9.32% |
| 2023-12-31 | €327.06 Million ≈ $382.37 Million |
-6.97% |
| 2022-12-31 | €351.56 Million ≈ $411.01 Million |
+186.66% |
| 2021-12-31 | €122.64 Million ≈ $143.38 Million |
-- |
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infus… Read more